HbA1c in the prediction of type 2 diabetes compared with fasting and 2-h post-challenge plasma glucose: The Asturias study (1998-2005);Valeur de l'HbA1c dans la prédiction du diabète de type 2: comparaison avec la glycémie à jeun et l'HGPO. Étude des Asturies 1998-2005

Diabetes and Metabolism

Volumn 37, Issue 1, 2011, Pages 27-32

  Valdes S ^a,b,c   Botas, P ^d   Delgado, E ^a   Alvarez F ^a   Diaz Cadorniga F ^a  

^a HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^b HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

^d HOSPITAL SAN AGUSTÍN   (Spain)

Author keywords

Asturias study; Epidemiology; Fasting blood glucose; HbA1c; OGTT; Predictive value; Type 2 diabetes

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; CARDIOVASCULAR RISK; CAUCASIAN; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DIET RESTRICTION; DISEASE COURSE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HEALTH SURVEY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; POPULATION RESEARCH; PREVALENCE; RECEIVER OPERATING CHARACTERISTIC; SPAIN;

ADULT; AGE OF ONSET; AGED; DATA COLLECTION; DIABETES MELLITUS, TYPE 2; DISEASE PROGRESSION; FASTING; FOLLOW-UP STUDIES; GLUCOSE TOLERANCE TEST; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERGLYCEMIA; MIDDLE AGED; PREDIABETIC STATE; PREDICTIVE VALUE OF TESTS; PREVALENCE; PROSPECTIVE STUDIES; RISK FACTORS; SPAIN;

EID: 79951770297     PISSN: 12623636     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabet.2010.07.002     Document Type: Article

References (20)

1. Rohlfing C.L., Wiedmeyer H.M., Little R.R., England J.D., Tennill A., Goldstein D.E. Defining the relationship between plasma glucose and HbA(1c): analysis of glucose profiles and HbA(1c): in the Diabetes Control and Complications Trial. Diabetes Care 2002, 25:275-278.
2. Woerle H.J., Pimenta W.P., Meyer C., Gosmanov N.R., Szoke E., Szombathy T., et al. Diagnostic and therapeutic implications of relationships between fasting, 2-hour postchallenge plasma glucose and hemoglobin a1c values. Arch Intern Med 2004, 164:1627-1632.
3. Nathan D.M., Turgeon H., Regan S. Relationship between glycated haemoglobin levels and mean glucose levels over time. Diabetologia 2007, 50:2239-2244.
4. Barr R.G., Nathan D.M., Meigs J.B., Singer D.E. Tests of glycemia for the diagnosis of type 2 diabetes mellitus. Ann Intern Med 2002, 137:263-272.
5. Rohlfing C., Wiedmeyer H.M., Little R., Grotz V.L., Tennill A., England J., et al. Biological variation of glycohemoglobin. Clin Chem 2002, 48:1116-1118.
6. Little R.R., Rohlfing C.L., Tennill A.L., Connolly S., Hanson S. Effects of sample storage conditions on glycated hemoglobin measurement: evaluation of five different high performance liquid chromatography methods. Diabetes Technol Ther 2007, 9:36-42.
7. Consensus statement on the worldwide standardization of the hemoglobin A1C measurement: american Diabetes Association, European Association for the Study of Diabetes, International Federation of Clinical Chemistry and Laboratory Medicine, and the International Diabetes Federation. Diabetes Care 2007, 30:2399-2400. Consensus Committee.
8. International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care 2009, 32:1327-1334. The International Expert Committee.
9. Little R.R., England J.D., Wiedmeyer H.M., Madsen R.W., Pettitt D.J., Knowler W.C., et al. Glycated haemoglobin predicts progression to diabetes mellitus in Pima Indians with impaired glucose tolerance. Diabetologia 1994, 37:252-256.
10. Ko G.T., Chan J.C., Tsang L.W., Cockram C.S. Combined use of fasting plasma glucose and HbA1c predicts the progression to diabetes in Chinese subjects. Diabetes Care 2000, 23:1770-1773.
11. Edelman D., Olsen M.K., Dudley T.K., Harris A.C., Oddone E.Z. Utility of hemoglobin A1c in predicting diabetes risk. J Gen Intern Med 2004, 19:1175-1180.
12. Norberg M., Eriksson J.W., Lindahl B., Andersson C., Rolandsson O., Stenlund H., et al. A combination of HbA1c, fasting glucose and BMI is effective in screening for individuals at risk of future type 2 diabetes: OGTT is not needed. J Intern Med 2006, 260:263-271.
13. Droumaguet C., Balkau B., Simon D., Caces E., Tichet J., Charles M.A., et al. DESIR Study Group. Use of HbA1c in predicting progression to diabetes in French men and women: data from an Epidemiological Study on the Insulin Resistance Syndrome (DESIR). Diabetes Care 2006, 29:1619-1625.
14. Inoue K., Matsumoto M., Kobayashi Y. The combination of fasting plasma glucose and glycosylated hemoglobin predicts type 2 diabetes in Japanese workers. Diabetes Res Clin Pract 2007, 77:451-458.
15. Sato K.K., Hayashi T., Harita N., Yoneda T., Nakamura Y., Endo G., et al. Combined measurement of fasting plasma glucose and A1C is effective for the prediction of type 2 diabetes: the Kansai Healthcare Study. Diabetes Care 2009, 32:644-646.
16. Valdes S., Botas P., Delgado E., Diaz-Cadorniga F.J., Alvarez F. Population-based incidence of type 2 diabetes in northern Spain. The " Asturias Study" Diabetes Care 2007, 30:2258-2263.
17. World Health Organization: Definition, Diagnosis and Classification of Diabetes Mellitus and Its Complications. Report of a WHO Consultation. Part 1: Diagnosis and Classification of Diabetes Mellitus. Geneva, World Health Org. 1999.
18. Hoelzel W., Weykamp C., Jeppsson J.O., Miedema K., Barr J.R., Goodall I., et al. IFCC reference system for measurement of hemoglobin A1C in human blood and the national standardization schemes in the United States, Japan, and Sweden: a method-comparison study. Clin Chem 2004, 50:166-174.
19. Shaw J.E., Hodge A.M., De Courten M., Chitson P., Zimmet P.Z. Isolated post-challenge hyperglycaemia confirmed as a risk factor for mortality. Diabetologia 1999, 42:1050-1054.
20. Is the current definition for diabetes relevant to mortality risk from all causes and cardiovascular and noncardiovascular diseases?. Diabetes Care 2003, 26:688-696. DECODE Study Group.